Evidence map›Paper›PMID 40196514›Full record

ArticlebioRxiv : the preprint server for biology2025

omicsGMF: a multi-tool for dimensionality reduction, batch correction and imputation applied to bulk- and single cell proteomics data.

Alexandre Segers, Cristian Castiglione, Christophe Vanderaa, Lennart Martens, Davide Risso, Lieven Clement

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Alexandre SegersDepartment of Applied Mathematics, Computer Science and Statistics, Ghent University. Ghent, Belgium.ORCID 0009-0004-2028-7595
Cristian CastiglioneBocconi Institute for Data Science and Analytics, Bocconi University. Milan, Italy.ORCID 0000-0001-5883-4890
Christophe VanderaaDepartment of Applied Mathematics, Computer Science and Statistics, Ghent University. Ghent, Belgium.ORCID 0000-0001-7443-5427
Lennart MartensDepartment of Biomolecular Medicine, Ghent University. Ghent, Belgium.ORCID 0000-0003-4277-658X
Davide RissoDepartment of Statistical Sciences, University of Padova. Padova, Italy.ORCID 0000-0001-8508-5012
Lieven ClementDepartment of Applied Mathematics, Computer Science and Statistics, Ghent University. Ghent, Belgium.ORCID 0000-0002-9050-4370

Funding

Cancer Genomics: Integrative and Scalable Solutions in R/BioconductorU24CA289073 · NCI · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI Sean Davis, Levi Waldron · 2024 to 2026
$3.2M
NCI NIH HHS U24 CA289073
6 · The paper itself

Abstract

The unprecedented speed and sensitivity of mass spectrometry (MS) unlocked large-scale applications of proteomics and even enabled proteome profiling of single cells. However, this fast-evolving field is hindered by a lack of scalable dimensionality reduction tools that can compensate for substantial batch effects and missingness across MS runs. Therefore, we present omicsGMF, a fast, scalable, and interpretable matrix factorization method, tailored for bulk and single-cell proteomics data. Unlike current workflows that sequentially apply imputation, batch correction, and principal component analysis, omicsGMF integrates these steps into a unified framework, dramatically enhancing data processing and dimensionality reduction. Additionally, omicsGMF provides robust imputation of missing values, outperforming bespoke state-of-the-art imputation tools. We further demonstrate how this integrated approach increases statistical power to detect differentially abundant proteins in the downstream data analysis. Hence, omicsGMF is a highly scalable approach to dimensionality reduction in proteomics, that dramatically improves many important steps in proteomics data analysis.

Identifiers

PMID40196514
PMCPMC11974731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.